Vagus nerve stimulators (VNS) is a neuromodulation therapy approved by the United States Food and Drug Administration (FDA) as a palliative treatment for patients with both epilepsy and depressions. Other non-FDA-approved uses of VNS have been studied and explored in various small open-labeled studies which include...
Find MoreLive Coverage of ASCO 2024 Visit Now for Real-Time Insights and Analytical, Impactful Updates!